Skip to Content
Merck

Skip To

1.03818

Supelco

1-Butylpyrrolidin-2-one

greener alternative

Synonym(s):

1-Butylpyrrolidin-2-one

Sign Into View Organizational & Contract Pricing

Select a Size

Change View
1 EA
₹4,550.00

About This Item

CAS Number:
MDL number:
UNSPSC Code:
12352111
NACRES:
NA.21
Assay:
≥99.5% (GC)

₹4,550.00


Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

product line

EMPLURA®

Quality Level

Assay

≥99.5% (GC)

form

liquid

greener alternative product characteristics

Safer Solvents and Auxiliaries
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

impurities

≤0.1% Alkalinity (as butylamine)
≤0.1% Water

color

≤50, Hazen

greener alternative category

storage temp.

2-30°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
1.167381.082921.06014
assay

≥99.5% (GC)

assay

≥99.5%

assay

≥99% (GC)

assay

≥99% (GC)

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

liquid

form

liquid

form

liquid

form

liquid

impurities

≤0.1% Alkalinity (as butylamine), ≤0.1% Water

impurities

≤0.002% Free acid (as C2H5COOH), ≤0.1% Water, ≤0.29% 2-Methoxypropan-1-ol (GC), ≤100 ppb Fe (Iron), ≤1000 ppb Na (Sodium), ≤20 ppb Al (Aluminium), ≤20 ppb Cu (Copper), ≤20 ppb Ni (Nickel), ≤20 ppb Zn (Zinc), ≤50 ppb Ca (Calcium), ≤50 ppb K (Potassium)

impurities

-

impurities

≤0.002% Free acid (as CH3COOH), ≤0.1% Water

product line

EMPLURA®

product line

EMPLURA®

product line

EMPLURA®

product line

EMPLURA®

greener alternative product characteristics

Safer Solvents and Auxiliaries
Learn more about the Principles of Green Chemistry.

greener alternative product characteristics

-

greener alternative product characteristics

Safer Solvents and Auxiliaries
Use of Renewable Feedstocks
Learn more about the Principles of Green Chemistry.

greener alternative product characteristics

-

General description

1-Butylpyrrolidin-2-one is a safer alternative to N-Methyl-2-pyrrolidone (NMP), N,N-Dimethylacetamide (DMA), Dimethyl sulfoxide (DMSO) and N,N-Dimethylformamide (DMF), which face increasing regulatory pressure. As opposed to NMP, DMF and DMA, 1-Butylpyrrolidin-2-one is not classified as developmentally reprotoxic.

EMPLURA® is our low-cost alternative to high-purity qualities. With EMPLURA we offer a range of solvents for a plurality of basic applications in non-regulated industries and for less demanding applications, preparative laboratory work and cleaning purposes. EMPLURA solvents provide adequate specifications with the most important parameters.

Benefits:
  • Excellent solvency power and water miscibility
  • High boiling point
  • High chemical and thermal stability
  • Not classified as a developmental[1]or geno-toxin
  • inherently bio-degradable
  • Lower volatility compared to NMP
  • Reliable alternative for REACH-restricted DMA, DMF, NMP

Legal Information

EMPLURA is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

10 - Combustible liquids

WGK

WGK 1


  • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Select a Product Number

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Methotrexate determination in pharmaceuticals by enantioselective HPLC
    El-Hady DA, et al.
    Journal of Pharmaceutical and Biomedical Analysis, 37(5), 919-925 (2005)
    Determination of methotrexate in plasma by on-column concentration and ion-exchange chromatography
    Lankelma J and Poppe H
    Journal of Chromatography A, 149(5), 587-598 (1978)
    Methotrexate mechanism in treatment of rheumatoid arthritis
    Friedman B and Cronstein B
    Joint, Bone, Spine : Revue du Rhumatisme, 86(3), 301-307 (2018)
    Methotrexate bioavailability after oral and intramuscular administration in children
    Teresi ME, et al.
    The Journal of Pediatrics, 110(5), 788-792 (1987)
    Fetal methotrexate syndrome: A systematic review of case reports
    Verberne EA, et al.
    Reproductive Toxicology, 87, 125-139 (2019)

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service